Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

CRVSCRVS
Showing 8 of 15 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in CORVUS PHARMACEUTICALS INC

Yes. Bank of America holds 757,798 shares of CRVS (Corvus Pharmaceuticals), worth $11.3M, as of its Q2 2026 13F filing. It increased the position from 237,004 shares in Q1 2026. Bank of America has held CRVS since Q2 2024, across 9 quarterly 13F filings.

Current Value

$11.3M

Current Shares

757,798

Total Value Change

+$11.3M

Total Shares Change

+757,389

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
757,798
+219.7%
$11.3M0.0%$14.94
45
2026-Q1
Increased
237,004
+0.2%
$3.5M0.0%$17.53
26
2025-Q4
Increased
236,495
+55.6%
$1.8M0.0%$7.49
36
2025-Q3
Increased
151,966
+14.5%
$1.1M0.0%$7.28
29
2025-Q2
Increased
132,729
+34.7%
$530,9160.0%$3.89
21
2025-Q1
Increased
98,549
+1.6%
$313,3850.0%$3.38
16
2024-Q4
Increased
96,981
+236x
$518,8480.0%$5.25
27
2024-Q3
Increased
409
+4.3%
$2,1600.0%$5.15
8

Other major holders of CRVS: BlackRock, Inc., STATE STREET CORP, PRICE T ROWE ASSOCIATES INC /MD/

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used